TruAlt Bioenergy reported a consolidated net profit of ₹592.71 lakh for the quarter ended June 30, 2026, marking a significant turnaround from the ₹47.25 lakh profit recorded in the corresponding quarter of FY25. The surge in profitability was underpinned by a 106% year-on-year increase in revenue from operations, which reached ₹6,268.83 lakh. EBITDA margin expanded to 21.18% from 13.67% in the year-ago period, reflecting improved operational efficiency and higher throughput in the company's core ethanol business, despite rising input costs.

The Board of Directors approved the unaudited standalone and consolidated financial results at a meeting held on July 28, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by statutory auditors N. M. Rajji & Co., who issued an unmodified report. The filing was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Highlights

The table below summarises key consolidated financial metrics for the quarter:

Consolidated total income stood at ₹6,414.08 lakh, up from ₹3,266.33 lakh in Q1FY25. Other income declined to ₹145.25 lakh from ₹227.42 lakh in the prior year, but this was more than offset by the jump in operating revenue. Total expenses increased to ₹5,629.62 lakh from ₹3,208.34 lakh, primarily due to higher cost of materials consumed (₹3,335.23 lakh vs ₹734.91 lakh) and changes in inventories of finished goods (₹476.88 lakh vs ₹1,237.22 lakh).

Segment Performance

The company operates in two reportable segments: Ethanol and other products, and Compressed Biogas. The ethanol segment contributed ₹6,156.77 lakh to revenue, accounting for nearly 98% of total operations, and delivered a segment result of ₹2,258.44 lakh. In contrast, the compressed biogas segment generated ₹112.06 lakh in revenue with a segment result of ₹92.42 lakh.

What the Numbers Show

The dramatic improvement in net profit is largely attributable to the scale-up in ethanol production and sales, which drove revenue growth significantly ahead of expense increases. The expansion in EBITDA margin to 21.18% from 13.67% year-on-year further underscores the improvement in operating profitability. While cost of materials consumed rose sharply, the contribution margin in the ethanol segment expanded substantially, indicating better pricing power or operational leverage. However, the pending updation of the fixed assets register for Unit 4, as highlighted in the auditor's emphasis of matter, suggests that capitalisation processes for recent feedstock conversion investments are still being finalised, which may impact future depreciation charges.

Standalone results mirrored the consolidated trend, with net profit reaching ₹550.06 lakh against ₹2.57 lakh in Q1FY25. Standalone revenue from operations was ₹6,159.22 lakh, up from ₹2,939.35 lakh. Earnings per share on a standalone basis were ₹6.41, compared to ₹0.00 in the previous year. No dividend was declared for the quarter.

TruAlt Bioenergy has appointed Deepak Sadhu as the scrutinizer for its 5th Annual General Meeting (AGM) to oversee the remote e-voting process. The Board of Directors approved the appointment during a meeting held on July 28, 2026, ensuring that shareholder voting is conducted in a fair and transparent manner in compliance with regulatory requirements.

The appointment aligns with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as well as Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administrations) Rules, 2014. Deepak Sadhu, a practicing company secretary with Membership No. 39541 and Certificate of Practice No. 14992, has consented to act as the independent scrutinizer for the event.

Scrutinizer Details

Deepak Sadhu is associated with Deepak Sadhu Company, a peer-reviewed firm holding Peer Review Number 2387/2022. His consent letter confirms eligibility, absence of disqualification under applicable laws, and commitment to maintaining confidentiality regarding voting results until official declaration. He will submit his final report to the Chairperson or authorized person within the prescribed timeframe.

The Board meeting commenced at 2:30 p.m. (IST) and concluded at 6:15 p.m. (IST). Monu Kumar, Company Secretary and Compliance Officer (M. No.: A38853), signed the intimation letter submitted to both BSE Limited and the National Stock Exchange of India Limited. Vijaykumar Murugesh Nirani, Managing Director, signed the formal appointment letter issued to the scrutinizer.

All relevant documents, including the appointment and consent letters, have been made available on the company’s website at www.trualtbioenergy.com . This procedural step ensures compliance with corporate governance norms and facilitates transparent shareholder participation in the upcoming AGM.